Naoki Kashihara

Kawasaki Medical School — Japan

Medicine · Health Sciences

55h-index13.3kcitations510works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Kidney Disease and Diabetes(123), Renal Diseases and Glomerulopathies(69), Dialysis and Renal Disease Management(55), Diabetes Treatment and Management(51), Blood Pressure and Hypertension Studies(40)

Publications496 total

Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages
American Journal of Physiology-Renal Physiology·2025Open Access
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex
Clinical and Experimental Nephrology·2025Open Access
Iptacopan in Patients With IgA Nephropathy From East Asia
Kidney International Reports·2025Open Access
Adenosine-mediated Neutrophil Regulation by Dapagliflozin Attenuates Renal Ischemia/Reperfusion Injury: Real-time Imaging and Metabolic Insights
Transplantation·2025· 1 cited
The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria
Nephrology Dialysis Transplantation·2025Open Access
Artificial-Intelligence-Based Trajectory Clustering Analysis Identifies High-Risk and Previously Overlooked Patients with CKD
Journal of the American Society of Nephrology·2025
Esaxerenone Ameliorates Glomerular Hyperfiltration in Diabetic Kidney Disease by Restoring Tubuloglomerular Feedback via Macula Densa MR Blockade
Journal of the American Society of Nephrology·2025
Assessment and Treatment of Metabolic Acidosis in CKD: Registry-Based Study
Journal of the American Society of Nephrology·2025
#2626 Effect of iptacopan discontinuation on proteinuria and complement biomarkers in patients with immunoglobulin A nephropathy (IgAN): a post hoc analysis from a Phase II trial
Nephrology Dialysis Transplantation·2025Open Access
Biomarker Insights from the Phase 3 APPLAUSE-IgAN Study: Iptacopan's Proteomic Signature in IgAN
Journal of the American Society of Nephrology·2025
Real-World SGLT2 Inhibitor (SGLT2i) Use in Patients with CKD in Japan
Journal of the American Society of Nephrology·2025
Mineralocorticoid Receptor-TRPC5 Axis Drives Macrophage-Mediated Inflammation in Diabetic Kidney Disease
Journal of the American Society of Nephrology·2025
Real-World SGLT2 Inhibitor (SGLT2i) Use in Patients with CKD in the United States
Journal of the American Society of Nephrology·2025· 1 cited
Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD
Nephrology Dialysis Transplantation·2025· 1 citedOpen Access
A Novel Framework for Evaluating the Clinical Reasoning Process of Large Language Models: A Comparative Study in Nephrology
2025Open Access
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease
Diabetes Therapy·2025· 1 citedOpen Access
Prediction of Estimated Glomerular Filtration Rate Slope and Kidney Prognosis of Patients with Chronic Kidney Disease
2025Open Access
Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan
Diabetes Obesity and Metabolism·2025· 1 citedOpen Access
Maintaining kidney health in aging societies: a JSN and ERA call to action
Nephrology Dialysis Transplantation·2025· 13 citedOpen Access
Author response for "Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan"
2025
page 1 of 25Next →

Frequent Co-authors

Minoru Satoh(11), Tamaki Sasaki(10), Hitoshi Sugiyama(9), Yashpal S. Kanwar(8), Hirofumi Makino(8), Yoshisuke Haruna(7), Hajime Nagasu(7), Hiddo J.L. Heerspink(7), Yoshitaka Morita(6), Kouichi Tamura(5), Eiichiro Kanda(5), Glenn M. Chertow(5), John J.V. McMurray(5), Peter Rossing(5), Anna Maria Langkilde(5), David C. Wheeler(5), Yoshio Terada(5), Takashi Shigematsu(5), Hirokazu Okada(5), Norio Komai(4)